LoadingLoadingLoadingNet selling: insiders sold $1.1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (1)
Citadel
$16.9M
added
Sells/Trims (2)
AQR
$129.3M
trimmed
Qube Research
$53.9M
sold
No tracked top-trader positions in ACGL as of Oct 21, 21:20 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 28, 2026
Period ending
Jun 30, 2026
Earnings per share
$2.46 expected
Estimates as of Oct 21, 2026
EPS expected
$1.51 to $2.68
Revenue expected
7 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | $2.56 / $2.46Yahoo Finance | +3.99% beat | $4.67B No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 28, 2026 | $2.50 / $2.46Yahoo Finance | +1.47% beat | $4.52B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Feb 9, 2026 | $2.98 / $2.57Yahoo Finance | +15.83% beat | $5.39B No estimate | Unavailable |
| Sep 30, 2025 | Oct 27, 2025 | $2.77 / $2.25Yahoo Finance | +22.87% beat | $5.11B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 29, 2025 | $2.58 / $2.30Alpha Vantage | +12.17% beat | $5.21B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 29, 2025 | $1.54 / $1.31Alpha Vantage | +17.56% beat | $4.67B No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Feb 10, 2025 | $2.26 / $1.80Alpha Vantage | +25.56% beat | $5.02B No estimate | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $2.56 / $2.10Alpha Vantage | +21.90% beat | $4.72B No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.98B | $5.39B | $4.36B | $4.47B |
| Cost of what it sold | $2.99B | $3.06B | $2.09B | $2.20B |
| Gross profit | $1.99B | $2.33B | $2.27B | $2.28B |
| What it spent | ||||
| Sales and admin | — | $79.0M | — | — |
| Other operating costs | $488.0M | $862.0M | $1.13B | $1.05B |
| Total operating expenses | $488.0M | $941.0M | $1.13B | $1.05B |
| What was left | ||||
| Operating profit | $1.50B | $1.39B | $1.15B | $1.22B |
| Interest on debt | $37.0M | $38.0M | $37.0M | $44.0M |
| Profit before tax | $1.56B | $1.45B | $1.15B | $1.22B |
| Tax | $215.0M | $210.0M | $98.0M | $164.0M |
| Net profit | $1.35B | $1.24B | $1.05B | $1.06B |
| EBITDA | $1.59B | $1.50B | $1.21B | $1.29B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Axa XL names former Everest exec to E&S casualty role
NeutralOct 19What's in the Cards for Globe Life This Earnings Season?
Leans bullishOct 19Unum Group's Premium Growth and Share Buybacks Support 2026 Outlook
Leans bullishOct 19What's in the Cards for Globe Life This Earnings Season?
Leans bullishOct 19What's in the Cards for Globe Life This Earnings Season?
Leans bullishOct 19What RenaissanceRe Bulls Got Right
NeutralOct 19The Pursuit of Compounding (@thepursuitofcompounding)
BullishOct 17Morgan Stanley cuts target for Arch Capital Group stock to USD 100
Leans bearishOct 17
